Literature DB >> 7446360

Hemodynamic, electrocardiographic, and metabolic effects of fructose diphosphate on acute myocardial ischemia.

A K Markov, N C Oglethorpe, T M Blake, P H Lehan, H K Hellems.   

Abstract

The hemodynamic, electrocardiographic, and metabolic responses of dogs with acute myocardial ischemia to intravenous administration of fructose-1,6-diphosphate (FDP) were assessed. Analysis of the results (compared to dextrose control) revealed evidence of major improvement of LVEDP and cardiac output, significant decrease of the ST segment, and large increases of ATP and CP in the ischemic district and to a lesser degree in the normally perfused myocardium. These results indicate that FDP intervenes in the Embden-Meyerhof pathway not only as a high energy substrate but also as a metabolic regulator influencing the activity of phosphofructokinase and that of pyruvate kinase. FDP also stimulates glycolysis in dog erythrocytes and increases their ATP and 2-3 DPG content by a factor of 2. The most significant finding in these studies is that this biochemical intervention appears to restore the depressed activity of glycolysis in ischemic myocardium.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7446360     DOI: 10.1016/0002-8703(80)90228-8

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  17 in total

1.  Use of an Escherichia coli recombinant producing thermostable polyphosphate kinase as an ATP regenerator to produce fructose 1,6-diphosphate.

Authors:  Seishi Iwamoto; Kei Motomura; Yasuharu Shinoda; Masaaki Urata; Junichi Kato; Noboru Takiguchi; Hisao Ohtake; Ryuichi Hirota; Akio Kuroda
Journal:  Appl Environ Microbiol       Date:  2007-07-06       Impact factor: 4.792

2.  The role of fructose-1,6-diphosphate in cell migration and proliferation in an in vitro xenograft blood vessel model of vascular wound healing.

Authors:  H H Cohly; J W Stephens; M F Angel; J C Johnson; A K Markov
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999-10       Impact factor: 2.416

Review 3.  Developmental cardiac metabolism in health and disease.

Authors:  M E Tripp
Journal:  Pediatr Cardiol       Date:  1989       Impact factor: 1.655

4.  Transport and metabolism of exogenous fumarate and 3-phosphoglycerate in vascular smooth muscle.

Authors:  D R Finder; C D Hardin
Journal:  Mol Cell Biochem       Date:  1999-05       Impact factor: 3.396

5.  Fructose-1,6-diphosphate reduces acute ECG changes due to doxorubicin in isolated rat heart.

Authors:  N Bernardini; R Danesi; M C Bernardini; M Del Tacca
Journal:  Experientia       Date:  1988-12-01

6.  Therapeutic action of fructose-1,6-diphosphate in traumatic shock.

Authors:  A K Markov; N Oglethorpe; M Grillis; W A Neely; H K Hellems
Journal:  World J Surg       Date:  1983-05       Impact factor: 3.352

7.  Experimental candidiasis in rabbits: protective action of fructose-1,6-diphosphate.

Authors:  R Tarsi; N Simonetti; C Orpianesi
Journal:  Mycopathologia       Date:  1983-02-17       Impact factor: 2.574

Review 8.  Metabolic intervention to affect myocardial recovery following ischemia.

Authors:  M K Pasque; A S Wechsler
Journal:  Ann Surg       Date:  1984-07       Impact factor: 12.969

9.  Exogenous fructose-1,6-bisphosphate is a metabolizable substrate for the isolated normoxic rat heart.

Authors:  B Tavazzi; J W Starnes; G Lazzarino; D Di Pierro; E M Nuutinen; B Giardina
Journal:  Basic Res Cardiol       Date:  1992 May-Jun       Impact factor: 17.165

10.  Beneficial effects of fructose-1,6-diphosphate infusion on liver regeneration after ischemic liver injury.

Authors:  T Nakai; H Tanimura; K Tabuse; Y Nagai; K Mori; H Yamoto
Journal:  Gastroenterol Jpn       Date:  1991-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.